Search for Terms or Answers
Dr. Shivani Garg is an Associate Professor in the Section of Rheumatology at the Yale School of Medicine, where she serves as Director of the Yale Lupus Clinical Research Program and co‑Director of the Yale Lupus Program. Her research aims to transform lupus care through precise and personalized approaches that address gaps in cardiovascular risk management, optimize therapeutic drug monitoring, and support shared decision‑making for patients with lupus and lupus nephritis.
Hydroxychloroquine (HCQ) is one of the most important drugs in rheumatology, especially for systemic lupus erythematosus (SLE). It reduces flares, organ damage, cardiovascular events, and pregnancy complications, and it improves survival.
Read ArticleBy downloading this material, I acknowledge that it may be used only for personal use and personal education and that I will accredit RheumNow.com as the source and owner of this material. Commercial use or mass reproduction of this material without permission from RheumNow (info@rheumnow.com) is prohibited.
